PL3165530T3 - Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V) - Google Patents

Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V)

Info

Publication number
PL3165530T3
PL3165530T3 PL15814466T PL15814466T PL3165530T3 PL 3165530 T3 PL3165530 T3 PL 3165530T3 PL 15814466 T PL15814466 T PL 15814466T PL 15814466 T PL15814466 T PL 15814466T PL 3165530 T3 PL3165530 T3 PL 3165530T3
Authority
PL
Poland
Prior art keywords
aryl phosphorus
spirocyclic
sulfide
aryl
oxide
Prior art date
Application number
PL15814466T
Other languages
English (en)
Polish (pl)
Inventor
Zhaozhong DING
Jinqing HU
Shuhui Chen
Xile LIU
Yidong Zhu
Chuanwen Fan
Baoping Zhao
Long Zhang
Yingying Yang
Qingmei ZHENG
Shansong ZHENG
Haiwen WAN
Jinging Hu
Original Assignee
Qilu Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410317076.7A external-priority patent/CN105330698B/zh
Application filed by Qilu Pharmaceutical Co., Ltd filed Critical Qilu Pharmaceutical Co., Ltd
Publication of PL3165530T3 publication Critical patent/PL3165530T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65615—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing a spiro condensed ring system of the formula where at least one of the atoms X or Y is a hetero atom, e.g. S

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL15814466T 2014-07-04 2015-06-29 Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V) PL3165530T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410317076.7A CN105330698B (zh) 2014-07-04 2014-07-04 螺环芳基磷氧化物和硫化物
CN201510350019 2015-06-23
EP15814466.7A EP3165530B1 (en) 2014-07-04 2015-06-29 Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
PCT/CN2015/082605 WO2016000581A1 (zh) 2014-07-04 2015-06-29 螺环芳基磷氧化物和芳基磷硫化物

Publications (1)

Publication Number Publication Date
PL3165530T3 true PL3165530T3 (pl) 2019-07-31

Family

ID=55018447

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15814466T PL3165530T3 (pl) 2014-07-04 2015-06-29 Spirocykliczny arylowy tlenek fosforu (V) i arylowy siarczek fosforu (V)

Country Status (7)

Country Link
US (1) US10053477B2 (enExample)
EP (1) EP3165530B1 (enExample)
JP (1) JP6487527B2 (enExample)
ES (1) ES2714576T3 (enExample)
PL (1) PL3165530T3 (enExample)
TW (1) TWI571471B (enExample)
WO (1) WO2016000581A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6487527B2 (ja) 2014-07-04 2019-03-20 チル ファーマシューティカル カンパニー リミテッド スピロ環アリールリン酸化物及びアリールリン硫化物(spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide)
JP6717457B2 (ja) 2017-01-23 2020-07-01 シージャーズォアン サガシティ ニュー ドラッグ デベロップメント カンパニー リミテッド Wee1阻害剤としての1,2−ジヒドロ−3H−ピラゾロ[3,4−d]ピリミジン−3−オン誘導体
CN110944999A (zh) * 2017-08-01 2020-03-31 勃林格殷格翰国际有限公司 中间体化合物和方法
US20210009613A1 (en) * 2017-12-12 2021-01-14 Shenzhen Targetrx, Inc. Arylphosphine oxides for inhibiting kinase activity
EP3715343B1 (en) * 2017-12-21 2024-02-14 Shenzhen TargetRx, Inc. Diphenylaminopyrimidine compound for inhibiting kinase activity
WO2019201334A1 (zh) * 2018-04-20 2019-10-24 南京明德新药研发有限公司 二甲基氧膦类化合物
WO2020147702A1 (en) * 2019-01-17 2020-07-23 Betta Pharmaceuticals Co., Ltd Egfr inhibitors, compositions and methods thereof
UY38988A (es) 2019-12-19 2021-06-30 Janssen Pharmaceutica Nv Derivados espiráncos sustituidos de cadena lineal
JP7671362B2 (ja) * 2021-07-05 2025-05-01 チールー ファーマシューティカル カンパニー、リミテッド 医薬組成物、その製造方法及び使用
WO2023078411A1 (zh) * 2021-11-05 2023-05-11 南京明德新药研发有限公司 氮杂螺环化合物
WO2023138574A1 (zh) * 2022-01-18 2023-07-27 齐鲁制药有限公司 螺环芳基磷氧化物与抗vegf抗体的药物组合
WO2023138576A1 (zh) * 2022-01-18 2023-07-27 齐鲁制药有限公司 螺环芳基磷氧化物与抗egfr抗体的药物组合
CN118891264A (zh) * 2022-08-01 2024-11-01 齐鲁制药有限公司 螺环胺类芳基磷氧化合物的晶型及其制备方法
UY41082A (es) 2024-03-28 2025-08-29 Pi Industries Ltd Compuestos bicíclicos condensados y su uso como agentes de control de plagas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0305929D0 (en) 2003-03-14 2003-04-23 Novartis Ag Organic compounds
TWI389893B (zh) * 2007-07-06 2013-03-21 Astellas Pharma Inc 二(芳胺基)芳基化合物
JP2011523646A (ja) 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
US9273077B2 (en) * 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
CA2778265A1 (en) * 2009-11-02 2011-05-05 Abbott Laboratories Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
WO2011146945A2 (en) * 2010-05-21 2011-11-24 Cell Signaling Technology, Inc. Alk and ros kinase in cancer
KR20130139999A (ko) 2010-10-14 2013-12-23 어리어드 파마슈티칼스, 인코포레이티드 Egfr-유도된 암의 세포 증식을 억제하는 방법
FR2974088A1 (fr) 2011-04-12 2012-10-19 Pf Medicament Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
CN102731413A (zh) 2011-04-15 2012-10-17 上海医药工业研究院 一种脲类化合物、其制备方法、其中间体及其应用
WO2013138210A1 (en) 2012-03-14 2013-09-19 Ning Xi Substituted cyclic compounds and methods of use
CA2868258A1 (en) 2012-03-28 2013-10-03 Synta Pharmaceuticals Corp. Triazole derivatives as hsp90 inhibitors
JP6469567B2 (ja) * 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Egfr発動性がんの細胞増殖阻害用化合物
US20130310340A1 (en) * 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
WO2013177092A1 (en) 2012-05-23 2013-11-28 Sunshine Lake Pharma Co., Ltd. Substituted alkynyl pyridine compounds and methods of use
WO2013192512A1 (en) 2012-06-22 2013-12-27 Concert Pharmaceuticals, Inc. Derivatives of pyrazole-substituted amino-heteroaryl compounds
WO2014002922A1 (ja) 2012-06-26 2014-01-03 アステラス製薬株式会社 抗癌剤の併用による癌治療方法
EP2867233A1 (en) 2012-07-03 2015-05-06 Aurigene Discovery Technologies Limited 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
KR101446742B1 (ko) 2012-08-10 2014-10-01 한국화학연구원 N2,n4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
JP2015529665A (ja) 2012-08-27 2015-10-08 ツェーエムエム−フォルシュングスツェントルム フュア モレクラレ メディツィン ゲーエムベーハー Mth1阻害剤としてのアミノヘテロアリール化合物
JP6487527B2 (ja) 2014-07-04 2019-03-20 チル ファーマシューティカル カンパニー リミテッド スピロ環アリールリン酸化物及びアリールリン硫化物(spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide)

Also Published As

Publication number Publication date
WO2016000581A1 (zh) 2016-01-07
EP3165530B1 (en) 2018-12-05
ES2714576T3 (es) 2019-05-29
US10053477B2 (en) 2018-08-21
US20170129909A1 (en) 2017-05-11
EP3165530A4 (en) 2017-07-26
JP6487527B2 (ja) 2019-03-20
TWI571471B (zh) 2017-02-21
EP3165530A1 (en) 2017-05-10
TW201604202A (zh) 2016-02-01
JP2017521436A (ja) 2017-08-03

Similar Documents

Publication Publication Date Title
EP3165530A4 (en) Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
GB201708754D0 (en) Neuromodulation device
PL3119688T3 (pl) Zamknięcie
SG11201610831PA (en) Lithium-sulphur battery
GB201418399D0 (en) Traction control
SG10201509851YA (en) Travel facility
GB2525943B (en) Oven
ZA201703835B (en) Zinc phosphate complex
ZA201605262B (en) Closure assembly
IL238369A0 (en) Silicon compounds with functional azocarbonyl
PL3085669T3 (pl) Złożony tlenek litu
ZA201703728B (en) Zinc phosphate complex
GB201407161D0 (en) Linear accelerator
SI3033968T1 (sl) Pečica
PL3099980T3 (pl) Piekarnik
GB201404253D0 (en) Closure assembly
ZA201700156B (en) Closure
GB201411985D0 (en) Battery
GB201420268D0 (en) Closure
AU2014117V (en) Calkwr Callistemon hybrid
GB2554909B (en) Dexterity assessment
AU5490P (en) WES08 Westringia hybrid
GB201416094D0 (en) Tamper-proof cover
GB201417027D0 (en) Journey logger
GB201416510D0 (en) Charge buddies